Orthocell Ltd company information, Employees & Contact Information

Employment Hero, Tiimely, Orthocell and Pay.com.au founders vie for top tech award Startup Daily

Orthocell CEO Paul Anderson named finalist in 2025 EY Entrepreneur Of The Year awards Proactive financial news

Orthocell Expands to Canada with Remplir Nerve Wrap Launch Kalkine Media

Orthocell grows US distributors for Remplir The Australian

Biocurious: Having gained FDA approval, Orthocell is ready to ‘rock and roll’ in the US Stockhead

Orthocell says it has achieved all endpoints in pivotal of nerve repair product BiotechDispatch

Orthocell’s Remplir used in nerve-sparing prostate surgery The Australian

Orthocell's Remplir Drives Record Quarterly Revenue Surge on Expanding Hospital Adoption Kalkine Media

Why 4DMedical, DroneShield, Orthocell, and Resolute Mining shares are racing higher The Motley Fool Australia

Orthocell's Remplir™ used in robotic prostate surgery in Australia Proactive financial news

Trump’s pharma tariff threat a ‘cage-rattling exercise’ The West Australian

Break it Down: Orthocell’s Remplir builds strong US market momentum Stockhead

Why Elders, Netwealth, Orthocell, and Syrah shares are charging higher The Motley Fool Australia

Orthocell’s Remplir approved in key Hong Kong market The Australian

Orthocell advances US rollout of nerve repair product Remplir BiotechDispatch

Just The Facts: Orthocell, Altech Batteries, Provaris Energy | ASX:ATC, OTC:ALTHF Proactive financial news

Orthocell advances global expansion on back of strong sales The West Australian

Why DroneShield, Lynas, Novonix, and Orthocell shares are storming higher today The Motley Fool Australia

Why Evolution Mining, Orthocell, Platinum, and Turaco shares are charging higher The Motley Fool Australia

This company has entered a trading halt, is it about to announce FDA approval? The Motley Fool Australia

Break it Down: Orthocell’s pivotal path into US healthcare market Stockhead

Why DroneShield, Medibank, Orthocell, and Santana Minerals shares are pushing higher The Motley Fool Australia

Orthocell Delivers Record Growth, Eyes Global Rollout | ASX:OCC, OTC:ORHHF Proactive financial news

Orthocell’s nerve repair device gains Aussie momentum Proactive financial news

Breaking Out: Regenerative medicine play Orthocell’s run might just be getting started Stockhead

Sixth quarter of record revenue for Orthocell The Australian

Orthocell moves ahead on global market expansion with seven new regulatory applications BiotechDispatch

Orthocell gains Canada’s nod for Remplir The Australian

Orthocell (ASX:OCC) Achieves 6th Consecutive Revenue Record Kalkine Media

Orthocell posts third straight record quarter The Australian

Level achieved: Orthocell gains FDA approval for flagship nerve repair product Stockhead

Biocurious: With Singaporean approval ticked off, Orthocell eyes the crucial US nerve-repair market Stockhead

ASX Health Stocks: Orthocell seeks TGA approval; Race Oncology gets FDA nod Stockhead

Orthocell gains Thai nod for Remplir The Australian

Just the Facts: Orthocell enters Canadian market Proactive financial news

Orthocell: Repair and Regeneration intelligentinvestor.com.au

Regulators clear Orthocell’s nerve repair product for sale in Canada Australian Manufacturing Forum

Orthocell records first sales of Striate+ dental membrane in new European markets smallcaps.com.au

Breaking into new grounds: Orthocell eyes $75M Canadian market with game-changing nerve repair product Australian Manufacturing Forum

Orthocell completes all nerve repair surgeries in Remplir US market authorisation study BiotechDispatch

Orthocell’s nerve-repair product first sales in Singapore The Australian

Orthocell’s easy cell into US as it secures distributors The West Australian

Orthocell shares up 10% today; anticipates FDA approval in the coming weeks The Motley Fool Australia

Orthocell's Remplir added to Australia's Prostheses List BiotechDispatch

Why Orthocell, Paladin Energy, Telix, and Woodside shares are racing higher today The Motley Fool Australia

Orthocell kicks off comparator study for nerve repair device Remplir Proactive financial news

‘No need’: Orthocell won’t move production to avoid tariffs The West Australian

Orthocell finalises $17m from institutions The West Australian

Orthocell shares higher as WA biotech posts record revenue, boosted by nerve repair tech The West Australian

Orthocell adds to Remplir use cases businessnews.com.au

Why Bellevue Gold, DroneShield, Orthocell, and Restaurant Brands NZ shares are rising today The Motley Fool Australia

Why Bravura, Dateline, Orthocell, and Race Oncology shares are storming higher The Motley Fool Australia

Why Ansell, Capricorn Metals, Orthocell, and Sonic Healthcare shares are charging higher The Motley Fool Australia

Why Clinuvel, Orthocell, Vulcan, and Wildcat shares are storming higher The Motley Fool Australia

Tendon repair treatment’s step forward Geelong Advertiser

Perth doctors create groundbreaking non-surgical treatment for chronic tendon injuries 9News

Health & Biotech Stockhead